These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30541507)

  • 1. A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
    Noto T; Seto H; Fukuhara J; Murabayashi M; Yachie A; Ayusawa M; Morioka I
    BMC Pediatr; 2018 Dec; 18(1):386. PubMed ID: 30541507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.
    Takahara T; Shimizu M; Nakagishi Y; Kinjo N; Yachie A
    Rheumatol Int; 2015 Jan; 35(1):81-4. PubMed ID: 24917023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anakinra and hepatotoxicity in pediatric rheumatology: a case series.
    Martins FR; Azevedo AC; Ganhão S; Aguiar F; Rodrigues M; Brito I
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):112. PubMed ID: 37803456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
    Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
    Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease.
    Mizuta M; Shimizu M; Inoue N; Kasai K; Nakagishi Y; Takahara T; Hamahira K; Yachie A
    Mod Rheumatol; 2016 Nov; 26(6):929-932. PubMed ID: 27433933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
    Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
    Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
    Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
    World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases.
    Xia Y; Cui P; Li Q; Liang F; Li C; Yang J
    Braz J Med Biol Res; 2017 Feb; 50(2):e5958. PubMed ID: 28225869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
    Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Yasin S; Fall N; Brown RA; Henderlight M; Canna SW; Girard-Guyonvarc'h C; Gabay C; Grom AA; Schulert GS
    Rheumatology (Oxford); 2020 Feb; 59(2):361-366. PubMed ID: 31326996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Gorelik M; Fall N; Altaye M; Barnes MG; Thompson SD; Grom AA; Hirsch R
    J Rheumatol; 2013 Jul; 40(7):1191-9. PubMed ID: 23678162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels.
    Cunha BA; Pherez FM; Alexiadis V; Gagos M; Strollo S
    Heart Lung; 2010; 39(2):164-72. PubMed ID: 20207278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease.
    Kim SH; Song ES; Yoon S; Eom GH; Kang G; Cho YK
    Ann Lab Med; 2021 May; 41(3):318-322. PubMed ID: 33303717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
    Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
    J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Kawasaki Disease with Intussusception.
    Ueharu K; Asano T; Fukunaga R; Matsui R; Yoshida K; Miyatake-Sudoh C; Abe M; Fujita A; Ito Y
    J Nippon Med Sch; 2021 Jan; 87(6):346-349. PubMed ID: 32612012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping clinical features of systemic juvenile idiopathic arthritis and SARS-CoV-2-related multisystem inflammatory syndrome in children.
    Boyarchuk O; Kovalchuk T
    Reumatologia; 2023; 61(1):63-70. PubMed ID: 36998579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
    Mizuta M; Shimizu M; Irabu H; Usami M; Inoue N; Nakagishi Y; Wada T; Yachie A
    Rheumatology (Oxford); 2021 Jan; 60(1):231-238. PubMed ID: 32681176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis.
    Çakan M; Karadağ ŞG; Tanatar A; Ayaz NA
    Mod Rheumatol; 2020 Sep; 30(5):900-904. PubMed ID: 31462146
    [No Abstract]   [Full Text] [Related]  

  • 20. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
    Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.